This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

A Case Report of Seizure Induced by Bupropion Nasal Insufflation

Stanley Hill, PharmD; Harminder Sikand, PharmD; and Jonathan Lee, MD

Published: February 15, 2007

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Bupropion hydrochloride (HCl) is an aminoketone antidepressant currently approved by the U.S. Food and Drug Administration (FDA) for depression and smoking cessation. Off-label uses include treatment of attentiondeficit/ hyperactivity disorder, chronic fatigue, and cocaine dependence and adjunctive treatment for Parkinson’s disease. Bupropion is available in 3 formulations: immediaterelease (IR), sustained-release (SR), and extended-release (XL).

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 9

Quick Links: Addiction , Substance Use Disorders


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...